HPTN 052 and the future of HIV treatment and prevention

Lancet. 2011 Jul 16;378(9787):226. doi: 10.1016/S0140-6736(11)61118-5.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / economics
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • HIV Seronegativity
  • HIV Seropositivity*
  • Humans
  • Primary Prevention / methods
  • Primary Prevention / trends*
  • Program Development*
  • Public Health / trends
  • Randomized Controlled Trials as Topic
  • Risk Reduction Behavior*
  • Risk-Taking
  • Sexual Behavior*
  • Sexual Partners

Substances

  • Anti-HIV Agents